NFE2L2 and Parkinson disease: By activating Nrf2, MSC-EVsBDNF supported mitochondrial function and enhanced the overall resilience of dopaminergic neurons in the brains of MSC-EVsBDNF-treated PD mice, offering a potentially new therapeutic option for PD treatment [44].